Tianjiao Wang

Tianjiao Wang is an Associate Director in Clinical Biomarkers & Companion Diagnostics at Adaptimmune. They are responsible for leading biomarker strategy and operations in global clinical trials, particularly focusing on patient screening and enrollment for TCR-T therapies. Prior to this role, they worked as a Biomarker lead at Adagene and held various roles at Admera Health, University of Michigan, Iowa State University, and Xiamen University, specializing in biomarker assay development, oncology research, and translational medicine. They hold a Ph.D. in Molecular Cellular and Developmental Biology from Iowa State University.